10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

#o

#f

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/2/26 20:51
1/30/26
IONSIonis Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo Diagnostic13S.d-1,55431.940-49133D
2/2/26 16:36
1/26/26
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo Diagnostic23P.dm796.030131791I
1/7/26 16:05
1/5/26
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic810S.dm-3,4118.960-3801,874D
1/6/26 16:23
12/4/25
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic45S.d-2,15316.960-127105D
12/10/25 18:37
11/26/25
QDELQuidelortho CorpHealthDiagnIn Vitro & In Vivo Diagnostic67P.d90221.7804131173D
12/4/25 16:11
12/3/25
ICCCImmucell Corp /De/DEHealthDiagnIn Vitro & In Vivo Diagnostic23P.m965.0101916141D
11/17/25 13:12
11/17/25
VNRXVolitionrx LtdDEHealthDiagnIn Vitro & In Vivo Diagnostic11P70.350002013,597D
11/13/25 16:34
10/31/25
IMDXInsight Molecular Diagnostics Inc.CAHealthDiagnIn Vitro & In Vivo Diagnostic11M.ad00.0005036189D
11/10/25 17:01
11/7/25
IDXXIdexx Laboratories Inc /DeDEHealthDiagnIn Vitro & In Vivo Diagnostic12M.d11,419520.1102221D
11/10/25 17:01
11/7/25
IDXXIdexx Laboratories Inc /DeDEHealthDiagnIn Vitro & In Vivo Diagnostic12S.d-11,419520.110-2221D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact